MedGen Inc (MDIN)

[Alien Trader]

Clinical Study Reveals Snorenz is Effective



Clinical Study Reveals Snorenz is Effective

The clinical study, headed by Drs. Samuel A. Mickelson MD, FACS, ABSM and Andrew R. Golde, MD, was conducted at The Atlanta Snoring & Sleep Disorders Institute and the Advanced Ear Nose & Throat Associates PC. The study was also approved by the Institutional review board at Northside Hospital, Atlanta, Georgia.

The clinical (double blind) study concludes: "Data analysis showed (that Snorenz(R) produced) a statistically significant improvement and beneficial treatment effect on three outcomes measures including the snore index, snore 25 score and type 2 snoring. In a survey of bed partners, Snorenz(R) was 57.5% more effective than a placebo in reducing snoring. As compared to placebo, the use of Snorenz(R) reduced the number of snores per hour, improved quality of life as measured by the Snore 25 questionnaire, and altered the character of snoring." The clinical study further asserts, "This study has clearly shown that a commercially available product (Snorenz(R) Spray) can also be beneficial for snoring."